Navratil Ondrej, Duris Kamil, Juran Vilem, Neuman Eduard, Svoboda Karel, Smrcka Martin
Department of Neurosurgery, University Hospital Brno, Jihlavska 20, 62500, Brno, Czech Republic.
Acta Neurochir (Wien). 2017 Mar;159(3):543-547. doi: 10.1007/s00701-016-3070-3. Epub 2017 Jan 9.
Middle cerebral artery aneurysms (MCA aneurysms) belong to the most frequent type of intracranial aneurysms forming an intracerebral hematoma. The consequences of the hematoma-the laterality, the impact of ICH volume and size of the aneurysm with the final outcome of these patients had not been studied in detail in this location, and we focused on the analysis of these factors.
Patients with MCA aneurysms and associated intracerebral hematomas with a volume ≥10 ml were studied; these were treated from January 2006 to December 2015. During this period, more than 700 patients with spontaneous subarachnoid hemorrhage were admitted to the Department of Neurosurgery, University Hospital Brno. The data were collected from the subarachnoid hemorrhage database of the unit and from the local hospital registry. All consecutive patients at the treating center were involved in this retrospective study. We collected clinical data such as age, gender, aneurysm location, preoperative hematoma size, Hunt-Hess grade and type of surgical procedures. We focused on the analysis of the final outcome [Glasgow Outcome Scale (GOS) score] in relation to ICH volume, side of bleeding and finally the relationship between aneurysm size and the volume of ICH.
Fifty-eight patients with an MCA aneurysm and ICH were included; the mean age of this series was 59.4 years. Thirty-six patients (62%) had clinical status Hunt-Hess 4-5 on admission. The mean size of the intracerebral hematoma was 47.1 ml (10-133 ml). Most frequently, in 30 patients (52%), the hematoma had bled into the temporal lobe. Fifty three patients were operated on, and 5 were treated conservatively because of their poor condition. Twenty-three patients (40%) had a favorable Glasgow Outcome Scale score, and 35 (60%) had an unfavorable outcome including 20 patients (35%) who died. Of the 53 patients operated on, 20 (38%) underwent decompressive hemicraniectomy (DHC). Patients with an unfavorable outcome had significantly larger hematomas with a median size of 54 ml, whereas those with a favorable outcome had a median size of 26 ml (p = 0.0022). Larger hematomas were found on the right side. The cutoff volume for an unfavorable outcome in ICH was 25 ml. The outcomes were not related to the side of the ICH (p = 0.42), and the aneurysm size did not predetermine the ICH volume (p = 0.3159).
Our study confirms the benefit of the active treatment of patients with MCA aneurysms and associated ICH. A significant proportion of these patients achieves a favorable outcome. No association between the side of bleeding and outcome was demonstrated. Hematomas larger than 25 ml have a greater tendency to lead to an unfavorable outcome. The treatment decision-making process should not differ for either side.
大脑中动脉动脉瘤(MCA 动脉瘤)是颅内动脉瘤中最常见的类型,可形成脑内血肿。关于该部位血肿的后果——血肿的侧别、脑内血肿体积和动脉瘤大小对这些患者最终结局的影响,此前尚未进行详细研究,我们重点对这些因素进行分析。
对 2006 年 1 月至 2015 年 12 月期间收治的大脑中动脉动脉瘤合并脑内血肿且血肿体积≥10 ml 的患者进行研究。在此期间,布尔诺大学医院神经外科收治了 700 余例自发性蛛网膜下腔出血患者。数据收集自该科室的蛛网膜下腔出血数据库及当地医院登记处。治疗中心的所有连续患者均纳入本回顾性研究。我们收集了年龄、性别、动脉瘤位置、术前血肿大小、Hunt-Hess 分级及手术方式等临床数据。我们重点分析了与脑内血肿体积、出血侧别相关的最终结局[格拉斯哥预后评分(GOS)],以及动脉瘤大小与脑内血肿体积之间的关系。
纳入 58 例大脑中动脉动脉瘤合并脑内血肿患者;本系列患者的平均年龄为 59.4 岁。36 例患者(62%)入院时 Hunt-Hess 分级为 4 - 5 级。脑内血肿的平均大小为 47.1 ml(10 - 133 ml)。最常见的是,30 例患者(52%)的血肿破入颞叶。53 例患者接受了手术治疗,5 例因病情较差接受保守治疗。23 例患者(40%)格拉斯哥预后评分良好,35 例(60%)预后不良,其中 20 例患者(35%)死亡。在接受手术治疗的 53 例患者中,20 例(38%)接受了去骨瓣减压术(DHC)。预后不良的患者血肿明显更大,中位数大小为 54 ml,而预后良好的患者中位数大小为 26 ml(p = 0.0022)。右侧发现的血肿更大。脑内血肿预后不良的临界体积为 25 ml。结局与脑内血肿的侧别无关(p = 0.42),动脉瘤大小也不能预先决定脑内血肿体积(p = 0.3159)。
我们的研究证实了对大脑中动脉动脉瘤合并脑内血肿患者进行积极治疗的益处。这些患者中有相当一部分可获得良好结局。未证实出血侧别与结局之间存在关联。大于 25 ml 的血肿更易导致不良结局。治疗决策过程在两侧不应有所不同。